Skip to content

Changes in the Risk Factors of Coronary Heart Disease Observed After Scaling and Root Planing

Effect of Nonsurgical Periodontal Treatment on Systemic Risk Markers of Cardiovascular Disease Clinically and Biochemically: A Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02417376
Enrollment
70
Registered
2015-04-15
Start date
2013-05-31
Completion date
2014-10-31
Last updated
2017-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease, Periodontitis

Keywords

Coronary heart disease, Periodontitis, C-reactive protein, Blood pressure

Brief summary

The purpose of this study is to determine whether scaling and root planing as a periodontal intervention helps in improving the overall health of patients suffering from coronary heart disease.

Detailed description

This study is a randomized, outcome assessor blinded, parallel group, trial to evaluate the effect of non surgical periodontal treatment in the form of scaling and root planing on coronary heart disease patients. 70 clinically defined coronary heart disease (CHD) patients with mild to moderate periodontitis, were allocated into two groups- experimental and control, in a ratio of 1:1. Scaling and root planing was provided as the intervention to the experimental group. To the control group no periodontal intervention in any form was provided. The primary outcome assessed is the changes in C-reactive protein level at baseline and after 1, 3, and 6 months of periodontal intervention. The secondary outcomes assessed are lipid profile, white blood cells (WBC) profile, and blood pressure (systolic and diastolic) at baseline and after 1, 3, and 6 months of periodontal intervention. Periodontal parameters including plaque index (PI), gingival index (GI), bleeding on probing (BOP), periodontal probing depth (PPD), and clinical attachment loss (CAL) is also assessed at baseline and after 6 months. All these parameters were also compared with their corresponding values in the control group.

Interventions

DEVICEpiezoelectric ultrasonic scaler (frequency of 28-36 KHz)

Periodontal treatment in the form of scaling and root planing (SRP) is provided to the patients assigned to the experimental group, after baseline examination. Scaling is performed using piezoelectric ultrasonic scaler (frequency of 28-36 KHz) and root planing is performed using area specific Gracey curettes (set of 7 instruments number #1-14). SRP is completed in two appointments of 45 min to 1 hour, within 24 hours period.

set of 7 instruments number #1-14

Sponsors

Government College of Dentistry, Indore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and female \> 35 yrs of age * Clinically diagnosed stable CHD cases * No other systemic disease * Non-smoker * Advanced chronic gingivitis and mild to moderate chronic periodontitis (≥ 4 teeth with probing depth ≤ 5 mm) and ≥ 14 teeth (excluding third molars) * No periodontal therapy in the last 12 months.

Exclusion criteria

* Not fulfilling criteria of the defined CHD case * Present smoker * Pregnant or lactating females * Suffering from any other systemic disease like diabetes * Taking systemic antibiotic therapy in the last 3 months * Advanced chronic periodontitis (probing depth \> 5mm) and \<14 teeth (excluding third molars) * Received any periodontal therapy within last 12 months.

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in C-Reactive Protein Level at 6 MonthsBaseline and 6 monthsChange from baseline in high-sensitivity C-reactive protein level assessed quantitatively by immunoturbidimetric analysis at 6 months.

Secondary

MeasureTime frameDescription
Change From Baseline in C-Reactive Protein Level at 3 MonthBaseline and 3 monthsChange from baseline in high-sensitivity C-reactive protein level assessed quantitatively by immunoturbidimetric analysis at 3 months.
Change From Baseline in Lipid Profile at 1 MonthBaseline and 1 monthChange from baseline in lipid profile assessed at 1 month.
Change From Baseline in Lipid Profile at 3 MonthsBaseline and 3 monthsChange from baseline in lipid profile assessed at 3 months.
Change From Baseline in Lipid Profile at 6 Months.Baseline and 6 monthsChange from baseline in lipid profile assessed at 6 months.
Change From Baseline WBC Profile at 1 MonthBaseline and 1 monthChange from baseline in white blood cell profile assessed at 1 month.
Change From Baseline WBC Profile at 3 MonthsBaseline and 3 monthsChange from baseline in white blood cell profile assessed at 3 months.
Change From Baseline WBC Profile at 6 MonthsBaseline and 6 monthsChange from baseline in white blood cell profile assessed at 6 months.
Systolic Blood Pressure at 1 Month1 monthSystolic blood pressure at 1 month.
Systolic Blood Pressure at 3 Months3 monthsSystolic blood pressure at 3 months.
Change From Baseline in C-Reactive Protein Level at 1 MonthBaseline and 1 monthChange from baseline in high-sensitivity C-reactive protein level assessed quantitatively by immunoturbidimetric analysis at 1 month.
Change From Baseline Periodontal Parameter- Periodontal Probing Depth at 6 MonthsBaseline and 6 monthsChange from baseline in periodontal parameter- periodontal probing depth at 6 months.
Change From Baseline Periodontal Parameter- Gingival Index at 6 MonthsBaseline and 6 monthsChange from baseline in periodontal parameter- gingival index at 6 months. Scale ranges for Total Gingival Index - Minimum score (0) and maximum score (3). Score 0 represents better outcome and higher scores represent worst outcome. Score per person are calculated by taking average of scores for 6 sites of all teeth recorded.
Change From Baseline Periodontal Parameter- Plaque Index at 6 MonthsBaseline and 6 monthsChange from baseline in periodontal parameter- plaque index at 6 months. Scale ranges for Total Plaque Index - Minimum score (0) and maximum score (3). Score 0 represents better outcome and higher scores represent worst outcome. Score per person are calculated by taking average of scores for 6 sites of all teeth recorded.
Change From Baseline Periodontal Parameter- Bleeding on Probing at 6 MonthsBaseline and 6 monthsChange from baseline in periodontal parameter- bleeding on probing at 6 months.
Change From Baseline Periodontal Parameter- Clinical Attachment Loss at 6 MonthsBaseline and 6 monthsChange from baseline in periodontal parameter- clinical attachment loss at 6 months.
Diastolic Blood Pressure at 1 Month1 monthDiastolic blood pressure at 1 month.
Diastolic Blood Pressure at 3 Months3 monthsDiastolic blood pressure at 3 months.
Diastolic Blood Pressure at 6 Months6 monthsDiastolic blood pressure at 6 months.
Systolic Blood Pressure at 6 Months6 monthsSystolic blood pressure at 6 months.

Participant flow

Recruitment details

Total 100 CHD patients recruited from Cardiology department of MY hospital, Indore, were evaluated at department of Periodontology, GDC Indore, for final selection.

Participants by arm

ArmCount
Experimental
Periodontal intervention in the form of scaling and root planing by: 1. ultrasonic piezoelectric scaler (frequency of 28-36 KHz) and 2. gracey curets (set of 7 instruments number 1-14) to remove supra and subgingival calculus on teeth, is completed in two appointments of 45 to 60 min, within 24 hours piezoelectric ultrasonic scaler (frequency of 28-36 KHz): Periodontal treatment in the form of scaling and root planing (SRP) is provided to the patients assigned to the experimental group, after baseline examination. Scaling is performed using piezoelectric ultrasonic scaler (frequency of 28-36 KHz) and root planing is performed using area specific Gracey curettes (set of 7 instruments number #1-14). SRP is completed in two appointments of 45 min to 1 hour, within 24 hours period. Gracey curettes: set of 7 instruments number #1-14
35
Control
No periodontal intervention in any form.
35
Total70

Baseline characteristics

CharacteristicExperimentalControlTotal
Age, Continuous60.43 years
STANDARD_DEVIATION 10.31
60.21 years
STANDARD_DEVIATION 9.23
60.30 years
STANDARD_DEVIATION 9.56
Gender
Female
12 Participants9 Participants21 Participants
Gender
Male
23 Participants26 Participants49 Participants
Region of Enrollment
India
35 participants35 participants70 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Change From Baseline in C-Reactive Protein Level at 6 Months

Change from baseline in high-sensitivity C-reactive protein level assessed quantitatively by immunoturbidimetric analysis at 6 months.

Time frame: Baseline and 6 months

Population: All patients suffered from CHD and Periodontitis both.

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline in C-Reactive Protein Level at 6 Months6.30 mg/LStandard Deviation 7.53
ControlChange From Baseline in C-Reactive Protein Level at 6 Months4.94 mg/LStandard Deviation 2.04
Secondary

Change From Baseline in C-Reactive Protein Level at 1 Month

Change from baseline in high-sensitivity C-reactive protein level assessed quantitatively by immunoturbidimetric analysis at 1 month.

Time frame: Baseline and 1 month

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline in C-Reactive Protein Level at 1 Month6.21 mg/LStandard Deviation 1.92
ControlChange From Baseline in C-Reactive Protein Level at 1 Month4.31 mg/LStandard Deviation 2.43
Secondary

Change From Baseline in C-Reactive Protein Level at 3 Month

Change from baseline in high-sensitivity C-reactive protein level assessed quantitatively by immunoturbidimetric analysis at 3 months.

Time frame: Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline in C-Reactive Protein Level at 3 Month6.22 mg/LStandard Deviation 3.64
ControlChange From Baseline in C-Reactive Protein Level at 3 Month4.09 mg/LStandard Deviation 1.82
Secondary

Change From Baseline in Lipid Profile at 1 Month

Change from baseline in lipid profile assessed at 1 month.

Time frame: Baseline and 1 month

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline in Lipid Profile at 1 Month35.67 mg/dlStandard Deviation 21.67
ControlChange From Baseline in Lipid Profile at 1 Month25.20 mg/dlStandard Deviation 6.48
Secondary

Change From Baseline in Lipid Profile at 3 Months

Change from baseline in lipid profile assessed at 3 months.

Time frame: Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline in Lipid Profile at 3 Months33.70 mg/dlStandard Deviation 19.53
ControlChange From Baseline in Lipid Profile at 3 Months26.08 mg/dlStandard Deviation 7.14
Secondary

Change From Baseline in Lipid Profile at 6 Months.

Change from baseline in lipid profile assessed at 6 months.

Time frame: Baseline and 6 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline in Lipid Profile at 6 Months.32.39 mg/dlStandard Deviation 18.43
ControlChange From Baseline in Lipid Profile at 6 Months.26.24 mg/dlStandard Deviation 6.5
Secondary

Change From Baseline Periodontal Parameter- Bleeding on Probing at 6 Months

Change from baseline in periodontal parameter- bleeding on probing at 6 months.

Time frame: Baseline and 6 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline Periodontal Parameter- Bleeding on Probing at 6 Months38.97 percentage of sitesStandard Deviation 12.93
ControlChange From Baseline Periodontal Parameter- Bleeding on Probing at 6 Months83.20 percentage of sitesStandard Deviation 13.02
Secondary

Change From Baseline Periodontal Parameter- Clinical Attachment Loss at 6 Months

Change from baseline in periodontal parameter- clinical attachment loss at 6 months.

Time frame: Baseline and 6 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline Periodontal Parameter- Clinical Attachment Loss at 6 Months2.85 mmStandard Deviation 0.59
ControlChange From Baseline Periodontal Parameter- Clinical Attachment Loss at 6 Months2.78 mmStandard Deviation 0.64
Secondary

Change From Baseline Periodontal Parameter- Gingival Index at 6 Months

Change from baseline in periodontal parameter- gingival index at 6 months. Scale ranges for Total Gingival Index - Minimum score (0) and maximum score (3). Score 0 represents better outcome and higher scores represent worst outcome. Score per person are calculated by taking average of scores for 6 sites of all teeth recorded.

Time frame: Baseline and 6 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline Periodontal Parameter- Gingival Index at 6 Months0.49 Scores on a scaleStandard Deviation 0.19
ControlChange From Baseline Periodontal Parameter- Gingival Index at 6 Months1.32 Scores on a scaleStandard Deviation 0.13
Secondary

Change From Baseline Periodontal Parameter- Periodontal Probing Depth at 6 Months

Change from baseline in periodontal parameter- periodontal probing depth at 6 months.

Time frame: Baseline and 6 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline Periodontal Parameter- Periodontal Probing Depth at 6 Months1.78 mmStandard Deviation 0.54
ControlChange From Baseline Periodontal Parameter- Periodontal Probing Depth at 6 Months1.86 mmStandard Deviation 0.31
Secondary

Change From Baseline Periodontal Parameter- Plaque Index at 6 Months

Change from baseline in periodontal parameter- plaque index at 6 months. Scale ranges for Total Plaque Index - Minimum score (0) and maximum score (3). Score 0 represents better outcome and higher scores represent worst outcome. Score per person are calculated by taking average of scores for 6 sites of all teeth recorded.

Time frame: Baseline and 6 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline Periodontal Parameter- Plaque Index at 6 Months0.80 Scores on a scaleStandard Deviation 0.62
ControlChange From Baseline Periodontal Parameter- Plaque Index at 6 Months1.15 Scores on a scaleStandard Deviation 0.14
Secondary

Change From Baseline WBC Profile at 1 Month

Change from baseline in white blood cell profile assessed at 1 month.

Time frame: Baseline and 1 month

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline WBC Profile at 1 Month8023.33 per cmmStandard Deviation 2463.06
ControlChange From Baseline WBC Profile at 1 Month7448.00 per cmmStandard Deviation 912.01
Secondary

Change From Baseline WBC Profile at 3 Months

Change from baseline in white blood cell profile assessed at 3 months.

Time frame: Baseline and 3 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline WBC Profile at 3 Months7750 per cmmStandard Deviation 1727.62
ControlChange From Baseline WBC Profile at 3 Months8260 per cmmStandard Deviation 1830.76
Secondary

Change From Baseline WBC Profile at 6 Months

Change from baseline in white blood cell profile assessed at 6 months.

Time frame: Baseline and 6 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalChange From Baseline WBC Profile at 6 Months7553.33 per cmmStandard Deviation 1634.91
ControlChange From Baseline WBC Profile at 6 Months8384.00 per cmmStandard Deviation 1171.07
Secondary

Diastolic Blood Pressure at 1 Month

Diastolic blood pressure at 1 month.

Time frame: 1 month

ArmMeasureValue (MEAN)Dispersion
ExperimentalDiastolic Blood Pressure at 1 Month83.87 mmHgStandard Deviation 10.51
ControlDiastolic Blood Pressure at 1 Month76 mmHgStandard Deviation 9.98
Secondary

Diastolic Blood Pressure at 3 Months

Diastolic blood pressure at 3 months.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalDiastolic Blood Pressure at 3 Months80.67 mmHgStandard Deviation 9.66
ControlDiastolic Blood Pressure at 3 Months76.48 mmHgStandard Deviation 7.9
Secondary

Diastolic Blood Pressure at 6 Months

Diastolic blood pressure at 6 months.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalDiastolic Blood Pressure at 6 Months80.07 mmHgStandard Deviation 9.12
ControlDiastolic Blood Pressure at 6 Months76.64 mmHgStandard Deviation 7.78
Secondary

Systolic Blood Pressure at 1 Month

Systolic blood pressure at 1 month.

Time frame: 1 month

ArmMeasureValue (MEAN)Dispersion
ExperimentalSystolic Blood Pressure at 1 Month130.00 mmHgStandard Deviation 19.69
ControlSystolic Blood Pressure at 1 Month120.56 mmHgStandard Deviation 17.6
Secondary

Systolic Blood Pressure at 3 Months

Systolic blood pressure at 3 months.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalSystolic Blood Pressure at 3 Months125.47 mmHgStandard Deviation 16.27
ControlSystolic Blood Pressure at 3 Months118.56 mmHgStandard Deviation 14.23
Secondary

Systolic Blood Pressure at 6 Months

Systolic blood pressure at 6 months.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
ExperimentalSystolic Blood Pressure at 6 Months123.70 mmHgStandard Deviation 15.72
ControlSystolic Blood Pressure at 6 Months120.88 mmHgStandard Deviation 14.56

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026